Dingxie Liu

5PUBLICATIONS
4CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 10, 2022
Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer.

Dingxie Liu, Jonathan Benzaquen, Luc G T Morris

|May 11, 2022
Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer.

Dingxie Liu, Paul Hofman

|Jul 01, 2020
Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.

Dingxie Liu

|Jan 15, 2020
AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer.

Dingxie Liu

|Jan 16, 2019
Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis.

Dingxie Liu

Pageof 1

Frequent Collaborators

1 joint publications

Jonathan Benzaquen

1 joint publications

Luc G T Morris

1 joint publications

Marius Ilié

1 joint publications

Paul Hofman